METHODS OF TREATING OCULAR INFLAMMATORY DISEASES
The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity re...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
30.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents.
La présente invention se rapporte à des méthodes de traitement de maladies inflammatoires oculaires par l'administration de compositions pharmaceutiques ophtalmiques de roflumilast. L'administration de compositions pharmaceutiques ophtalmiques de roflumilast peut fournir une activité immunomodulatrice et anti-inflammatoire considérable par rapport aux thérapies immunomodulatrices, immunosuppressives ou anti-inflammatoires non stéroïdiennes existantes, comprenant des corticostéroïdes et des antihistaminiques, tout en fournissant également un profil de sécurité et de commodité amélioré par rapport à un ou aux deux agents. |
---|---|
Bibliography: | Application Number: WO2022US76876 |